Share

June 02, 2020; 94 (22) Invited Article

COVID-19 and neuromuscular disorders

Amanda C. Guidon, Anthony A. Amato
First published April 13, 2020, DOI: https://doi.org/10.1212/WNL.0000000000009566
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
17186

Share

Article Information

vol. 94 no. 22 959-969
DOI: 
https://doi.org/10.1212/WNL.0000000000009566
PubMed: 
32284362
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received April 5, 2020
  • Accepted in final form April 9, 2020
  • First Published April 13, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Amanda C. Guidon, MD and
    2. Anthony A. Amato, MD
  1. Amanda C. Guidon, MD and
    2. Scientific Advisory Boards:

    1. (1) Alexion (2) Ra Pharma

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) RaPharma (travel to investigator meeting) (2) Momenta Pharmaceuticals (travel to investigator meeting)

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Comprehensive Review of Neuromuscular and Electrodiagnostic Medicine, The Oakstone Institute, 2014, 2016 and 2018.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Momenta Pharmaceuticals

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. 1) Speaker honoraria (Massachusetts Neurologic Association) - CME activity

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) RaPharma - Clinical trial (2) Momenta Pharmaceuticals - Clinical trial (3) Spouse employed by GE Healthcare

    Research Support, Government Entities:

    1. 1) PCORI - PROMISE MG Study - Site PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1) Myasthenia Gravis Foundation of America Stock/Stock Options, Medical Equipment & Materials: Spouse owns General Electric (GE) stock, 2013 - present

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Anthony A. Amato, MD
    3. Scientific Advisory Boards:

    1. Medical Advisory Board for Alexion and Argenx

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Associate Editor for Neurology

    Patents:

    1. NONE

    Publishing Royalties:

    1. Amato AA, Russell J. Neuromuscular Disease (2nd Ed). New York: McGraw-Hill, 2016 Harrisons Principles of Internal Medicine (2th ed), New Your, McGraw-Hill, 2018 Up-to-Date

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Medical Consultant for Best Doctors

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Expert witness for defendant in medical malpractice cases

  1. From the Division of Neuromuscular Medicine, Department of Neurology, Massachusetts General Hospital (A.C.G.), and Division of Neuromuscular Medicine, Department of Neurology, Brigham and Woman's Hospital (A.A.A.), Harvard Medical School, Boston, MA.
  1. Correspondence
    Dr. Guidon aguidon{at}partners.org or Dr. Amato aamato{at}bwh.harvard.edu
View Full Text

Article usage

Article usage: May 2020 to May 2023

AbstractFullPdfSource
Apr 2020842804184Highwire
May 2020430252142Highwire
Jun 202035626551309Highwire
Jul 20202421900696Highwire
Aug 20201881524565Highwire
Sep 2020184934497Highwire
Oct 2020175774649Highwire
Nov 2020123890404Highwire
Dec 2020117816439Highwire
Jan 2021981308428Highwire
Feb 2021116987350Highwire
Mar 20211291246390Highwire
Apr 20211131148391Highwire
May 2021113826410Highwire
Jun 2021103739326Highwire
Jul 202169801405Highwire
Aug 202170925334Highwire
Sep 202174860342Highwire
Oct 202158858479Highwire
Nov 202164696250Highwire
Dec 202144683152Highwire
Jan 202258833193Highwire
Feb 202257641184Highwire
Mar 202266593198Highwire
Apr 202231477163Highwire
May 202240469185Highwire
Jun 202244340150Highwire
Jul 20222629090Highwire
Aug 202264243118Highwire
Sep 202230193114Highwire
Oct 20223024684Highwire
Nov 202228200119Highwire
Dec 20222319877Highwire
Jan 20233122780Highwire
Feb 20233423880Highwire
Mar 20233424888Highwire
Apr 202322222121Highwire

Cited By...

Letters: Rapid online correspondence

  • Reader response: COVID-19 and neuromuscular disorders
    • Tai-Heng Chen, Pediatric Neurologist, Kaohsiung Medical University Hospital, Kaohsiung Medical University
    • Jong-Hau Hsu, Pediatric Pulmonologist, Kaohsiung Medical University Hospital, Kaohsiung Medical University
    Submitted April 20, 2020
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles